PTPI
Petros Pharmaceuticals, Inc.Company with tickers: PTPI
CIK
1815903
CUSIP
71678J308
Shares Outstanding
42,372,260
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,458,349 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Research & Development | — | ||||
| Operating Income | $-1,458,349 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-2,260,022 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-9.37 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-9.37 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |